MEASUREMENT OF CIRCULATING MUTATION BURDEN
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age30-50
SponsorCentre Francois Baclesse
About this trial
Cancer-free women with a hereditary predisposition to breast and/or ovarian cancer
Eligibility criteria
Qualifiers
Female participant
Participant undergoing oncogenetic follow-up at the Centre François Baclesse
Participant belonging to a pair of related biological siblings
Within the sibling pair, one participant is a carrier of a hereditary predisposition linked to a BRCA1/2 mutation (case), and the other participant is not a carrier (control).
Disqualifiers
None
Trial design
Treatments tested in this trial
- Mutation Burden cfMB analysis
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov